HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) EV/EBITDA
As of 5 November 2026, HealthEquity, Inc. (HQY) trades at a EV/EBITDA of 18.2×. Over the past ten years it has ranged from 14.6× (February 2026) to 69.9× (September 2018); the current reading is higher than 6% of that period. That is above the Health Information Services industry median of 13.4× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2026 | 17.1× | (46.24%) |
| FY2025 | 31.7× | 24.82% |
| FY2024 | 25.4× | (24.08%) |
| FY2023 | 33.5× | (23.65%) |
| FY2022 | 43.9× | (1.23%) |
| FY2021 | 44.4× | 9.90% |
| FY2020 | 40.4× | 10.92% |
| FY2019 | 36.4× | (8.87%) |
| FY2018 | 40.0× | (14.09%) |
| FY2017 | 46.5× | 49.39% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jul 2026 | 17.8× | 16.23% |
| Apr 2026 | 15.3× | (10.18%) |
| Jan 2026 | 17.1× | (13.07%) |
| Oct 2025 | 19.6× | (15.47%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| WAY Waystar Holding Corp. compare | 15.0× |
| HQY HealthEquity, Inc. | 18.2× |
| BTSG BrightSpring Health Services, Inc. compare | 21.9× |
| DOCS Doximity, Inc. compare | 24.0× |
| PRVA Privia Health Group, Inc. compare | 41.1× |
| HNGE Hinge Health Inc. compare | 54.5× |
| Health Information Services industry median | 13.4× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on HQY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement